NSAM
BMY icon

North Star Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

North Star Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454K Sell
7,486
-1,594
-18% -$92.9K 0.02% 256
2025
Q4 		$490K Sell
9,080
-1,313
-13% -$63.2K 0.02% 243
2025
Q3 		$469K Sell
10,393
-540
-5% -$25.2K 0.02% 238
2025
Q2 		$506K Buy
10,933
+1,356
+14% +$66.6K 0.02% 223
2025
Q1 		$584K Sell
9,577
-2,448
-20% -$143K 0.03% 210
2024
Q4 		$680K Buy
12,025
+4,871
+68% +$272K 0.03% 200
2024
Q3 		$370K Sell
7,154
-642
-8% -$30.1K 0.02% 240
2024
Q2 		$324K Sell
7,796
-1,349
-15% -$60.4K 0.02% 250
2024
Q1 		$496K Buy
9,145
+2,434
+36% +$124K 0.02% 218
2023
Q4 		$344K Sell
6,711
-3,483
-34% -$183K 0.02% 240
2023
Q3 		$592K Sell
10,194
-297
-3% -$18.2K 0.03% 191
2023
Q2 		$671K Hold
10,491
– – 0.04% 182
2023
Q1 		$727K Sell
10,491
-200
-2% -$14.1K 0.04% 176
2022
Q4 		$769K Sell
10,691
-934
-8% -$70.4K 0.05% 171
2022
Q3 		$826K Sell
11,625
-412
-3% -$29.9K 0.06% 161
2022
Q2 		$927K Buy
12,037
+607
+5% +$46.2K 0.06% 157
2022
Q1 		$835K Sell
11,430
-32
-0.3% -$2.15K 0.05% 172
2021
Q4 		$715K Buy
11,462
+975
+9% +$57.2K 0.04% 189
2021
Q3 		$621K Buy
10,487
+1,700
+19% +$112K 0.03% 192
2021
Q2 		$587K Sell
8,787
-35
-0.4% -$2.28K 0.03% 199
2021
Q1 		$557K Hold
8,822
– – 0.03% 193
2020
Q4 		$547K Buy
8,822
+1,000
+13% +$61.5K 0.03% 188
2020
Q3 		$472K Buy
7,822
+40
+0.5% +$2.41K 0.03% 185
2020
Q2 		$458K Sell
7,782
-85
-1% -$5.08K 0.04% 185
2020
Q1 		$439K Sell
7,867
-6,815
-46% -$417K 0.04% 184
2019
Q4 		$942K Buy
14,682
+2,992
+26% +$171K 0.07% 152
2019
Q3 		$593K Sell
11,690
-250
-2% -$11.8K 0.05% 182
2019
Q2 		$541K Buy
11,940
+908
+8% +$42.3K 0.04% 191
2019
Q1 		$526K Sell
11,032
-1,425
-11% -$71K 0.04% 191
2018
Q4 		$648K Sell
12,457
-1,250
-9% -$67.2K 0.06% 169
2018
Q3 		$851K Sell
13,707
-80
-0.6% -$4.75K 0.07% 160
2018
Q2 		$763K Sell
13,787
-175
-1% -$9.45K 0.07% 165
2018
Q1 		$883K Sell
13,962
-640
-4% -$41.2K 0.08% 155
2017
Q4 		$895K Buy
14,602
+950
+7% +$59.4K 0.08% 155
2017
Q3 		$870K Sell
13,652
-135
-1% -$7.88K 0.09% 154
2017
Q2 		$768K Buy
13,787
+26
+0.2% +$1.42K 0.08% 158
2017
Q1 		$748K Buy
13,761
+758
+6% +$41.6K 0.08% 153
2016
Q4 		$760K Hold
13,003
– – 0.08% 154
2016
Q3 		$701K Buy
13,003
+130
+1% +$8.35K 0.08% 156
2016
Q2 		$947K Sell
12,873
-800
-6% -$56.5K 0.11% 143
2016
Q1 		$873K Buy
13,673
+617
+5% +$38.9K 0.1% 149
2015
Q4 		$898K Buy
13,056
+100
+0.8% +$6.61K 0.11% 152
2015
Q3 		$767K Buy
12,956
+1,965
+18% +$125K 0.1% 157
2015
Q2 		$731K Sell
10,991
-15
-0.1% -$989 0.08% 162
2015
Q1 		$710K Sell
11,006
-35
-0.3% -$2.19K 0.08% 163
2014
Q4 		$652K Hold
11,041
– – 0.07% 165
2014
Q3 		$565K Sell
11,041
-185
-2% -$9.24K 0.07% 169
2014
Q2 		$545K Buy
11,226
+338
+3% +$16.7K 0.06% 171
2014
Q1 		$566K Buy
10,888
+213
+2% +$11.3K 0.07% 168
2013
Q4 		$567K Hold
10,675
– – 0.07% 168
2013
Q3 		$494K Hold
10,675
– – 0.06% 174
2013
Q2 		$477K Buy
+10,675
New +$463K 0.07% 170

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

North Star Asset Management's BMY Position: Q1 2026 in Review

North Star Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, selling an estimated $92.9K and leaving 7,486 shares worth $454K. The position accounts for 0.02% of the portfolio, ranked #256.

North Star Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $947K in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • North Star Asset Management held 7,486 shares of Bristol-Myers Squibb worth $454K as of Q1 2026.
  • North Star Asset Management sold 1,594 Bristol-Myers Squibb shares in Q1 2026, an estimated $92.9K.
  • Bristol-Myers Squibb made up 0.02% of North Star Asset Management's portfolio in Q1 2026, its #256 holding.
  • North Star Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • North Star Asset Management's Bristol-Myers Squibb position peaked at $947K in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.